Related Experiment Video
Updated: Oct 30, 2025

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
Published on: March 20, 2017
Does bariatric surgery reduce future hospital costs? A propensity score-matched analysis using UK Biobank Study data
Tingting Wu1, Koen B Pouwels2, Richard Welbourn3
1Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Bariatric surgery increases initial hospital costs for obesity but leads to lower expenditures in subsequent years. However, the long-term cost savings do not fully offset the upfront surgical expenses within four years.
Area of Science:
- Health Economics
- Surgical Outcomes
- Obesity Management
Background:
- Obesity is a significant public health concern associated with increased healthcare utilization and costs.
- Bariatric surgery is an effective treatment for severe obesity, but its long-term economic impact requires thorough evaluation.
Purpose of the Study:
- To estimate and compare the hospital costs for individuals with obesity who underwent bariatric surgery versus those who did not.
- To analyze the short-term and long-term cost implications of bariatric surgery in a real-world healthcare setting.
Main Methods:
- Analysis of the UK Biobank Cohort linked to Hospital Episode Statistics (2006-2017) for adults with obesity.
- Propensity score matching (1:5 ratio) to compare 324 surgical patients with 1506 control participants who did not undergo surgery.
- Assessment of annual and cumulative hospital costs using inverse probability of censoring weighting.
Main Results:
- Bariatric surgery patients incurred significantly higher inpatient costs in the surgery year (€7289 vs. €2635, P < 0.001).
- Surgical patients experienced lower hospital costs in the four years following surgery compared to controls.
- Five-year cumulative hospital costs were €11,176 for surgical patients and €8759 for controls (P = 0.001).
Conclusions:
- Bariatric surgery leads to a substantial increase in inpatient costs during the year of the procedure.
- While subsequent years show decreased costs, these savings do not fully compensate for the initial surgical expenditure within a four-year timeframe.
- The economic evaluation highlights the trade-offs between immediate surgical investment and potential long-term healthcare savings in obesity management.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

